Cargando…
Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
More than 55 million people suffer from dementia, with this number projected to double every 20 years. In the United States, 1 in 3 aged individuals dies from Alzheimer’s disease (AD) or another type of dementia and AD kills more individuals than breast cancer and prostate cancer combined. AD is a c...
Autores principales: | Tobeh, Nour S., Bruce, Kimberley D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630922/ https://www.ncbi.nlm.nih.gov/pubmed/38020773 http://dx.doi.org/10.3389/fnagi.2023.1259012 |
Ejemplares similares
-
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021) -
Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
por: Xu, Yi-Jun, et al.
Publicado: (2022) -
Contribution of “Genuine Microglia” to Alzheimer's Disease Pathology
por: Hashioka, Sadayuki, et al.
Publicado: (2022) -
The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism
por: Long, Hui-Zhi, et al.
Publicado: (2022) -
Editorial: Expert opinions on the relationship between microglia, glia, and Alzheimer's disease: 2022
por: Gomez-Arboledas, Angela, et al.
Publicado: (2023)